S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

SWEDISH ORPHAN/S Stock Forecast, Price & News

-0.29 (-1.18 %)
(As of 04/9/2019)
Today's Range
Now: $24.38
50-Day Range
MA: $24.38
52-Week Range
Now: $24.38
Volume200 shs
Average Volume1,665 shs
Market Capitalization$6.64 billion
P/E Ratio48.76
Dividend YieldN/A
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.


Overall MarketRank

0.44 out of 5 stars

Medical Sector

1466th out of 1,558 stocks

Private Households Industry

318th out of 351 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Private households
Previous SymbolNASDAQ:SWTUY



Sales & Book Value

Annual Sales$763.19 million
Cash Flow$0.70 per share
Book Value$2.88 per share


Net Income$134.73 million


Market Cap$6.64 billion
Next Earnings DateN/A
OptionableNot Optionable
-0.29 (-1.18 %)
(As of 04/9/2019)
30 days | 90 days | 365 days | Advanced Chart

Receive SWTUY News and Ratings via Email

Sign-up to receive the latest news and ratings for SWTUY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Frequently Asked Questions

How has SWEDISH ORPHAN/S's stock been impacted by Coronavirus (COVID-19)?

SWEDISH ORPHAN/S's stock was trading at $24.38 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SWTUY shares have increased by 0.0% and is now trading at $24.38.
View which stocks have been most impacted by COVID-19

What stocks does MarketBeat like better than SWEDISH ORPHAN/S?

Wall Street analysts have given SWEDISH ORPHAN/S a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SWEDISH ORPHAN/S wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of SWEDISH ORPHAN/S's key competitors?

Who are SWEDISH ORPHAN/S's key executives?

SWEDISH ORPHAN/S's management team includes the following people:
  • Dr. Guido Oelkers, CEO & Pres (Age 54)
  • Mr. Henrik Stenqvist, Chief Financial Officer (Age 52)
  • Ms. Anne Marie de Jonge Schuermans, Head of Technical Operations
  • Ms. Paula Treutiger, Head of Communications & Investor Relations (Age 52)
  • Mr. Torbjörn Hallberg, Gen. Counsel & Head of Legal Affairs (Age 50)

What is SWEDISH ORPHAN/S's stock symbol?

SWEDISH ORPHAN/S trades on the OTCMKTS under the ticker symbol "SWTUY."

How do I buy shares of SWEDISH ORPHAN/S?

Shares of SWTUY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SWEDISH ORPHAN/S's stock price today?

One share of SWTUY stock can currently be purchased for approximately $24.38.

How big of a company is SWEDISH ORPHAN/S?

SWEDISH ORPHAN/S has a market capitalization of $6.64 billion and generates $763.19 million in revenue each year. The company earns $134.73 million in net income (profit) each year or $0.50 on an earnings per share basis. SWEDISH ORPHAN/S employs 902 workers across the globe.

What is SWEDISH ORPHAN/S's official website?

The official website for SWEDISH ORPHAN/S is www.sobi.com.

How can I contact SWEDISH ORPHAN/S?

SWEDISH ORPHAN/S's mailing address is Tomtebodavagen 23A, Stockholm V7, 112 76. The company can be reached via phone at 46-0-869-720-00 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.